Home » Topics » Regulatory » Patents

Patents
RSS

Substance P antagonists from Pfizer especially useful for pain, inflammation

April 28, 1998

Anti-MRSA carbapenems developed at Suntory

April 28, 1998

Lilly presents naphthalene and related compounds for postmenopausal therapy

April 28, 1998

Toagosei presents several related antitumor series

April 28, 1998

Gastric prokinetic/antiemetic agents from Dainippon

April 28, 1998

Toyama focuses on cephalosporins, particularly anti-MRSA compounds

April 27, 1998

Cathepsin inhibitors under study at Nippon Chemiphar

April 27, 1998

Baccatin derivatives with antitumor activity developed at Tanabe Seiyaku

April 27, 1998

Bronchodilating and antiinflammatory agents claimed by Nikken

April 27, 1998

Nitroquinoxalinediones for inhibiting neuronal cell death

April 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...